413 related articles for article (PubMed ID: 11818324)
1. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.
Ohnishi H; Yokoyama A; Kondo K; Hamada H; Abe M; Nishimura K; Hiwada K; Kohno N
Am J Respir Crit Care Med; 2002 Feb; 165(3):378-81. PubMed ID: 11818324
[TBL] [Abstract][Full Text] [Related]
2. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
[TBL] [Abstract][Full Text] [Related]
4. [New serum markers to monitor treatment of acute exacerbation of interstitial lung disease].
Otsuka M; Takahashi H; Fujisima T; Nishiyama K; Kon H; Outi H; Imai Y; Sakon O; Shiratori M; Abe S
Nihon Kokyuki Gakkai Zasshi; 2001 Apr; 39(4):298-302. PubMed ID: 11481832
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis.
Takahashi H; Kuroki Y; Tanaka H; Saito T; Kurokawa K; Chiba H; Sagawa A; Nagae H; Abe S
Am J Respir Crit Care Med; 2000 Jul; 162(1):258-63. PubMed ID: 10903251
[TBL] [Abstract][Full Text] [Related]
6. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
[TBL] [Abstract][Full Text] [Related]
7. Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease.
Al-Salmi QA; Walter JN; Colasurdo GN; Sockrider MM; Smith EO; Takahashi H; Fan LL
Chest; 2005 Jan; 127(1):403-7. PubMed ID: 15654008
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of serum surfactant proteins A and D in idiopathic interstitial pneumonia].
Honda Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():181-5. PubMed ID: 9216212
[TBL] [Abstract][Full Text] [Related]
9. [A case of severe Legionella pneumonia monitored with serum SP-A, SP-D, and KL-6].
Sukoh N; Yamamoto H; Kikuchi E; Suzuki T; Kamimura A; Watanabe N; Takahashi H; Abe S; Tateda K
Nihon Kokyuki Gakkai Zasshi; 2001 Feb; 39(2):126-30. PubMed ID: 11321824
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
Asano Y; Ihn H; Yamane K; Yazawa N; Kubo M; Fujimoto M; Tamaki K
Arthritis Rheum; 2001 Jun; 44(6):1363-9. PubMed ID: 11407696
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of the serum surfactant protein D and KL-6 levels in patients with measles complicated by interstitial pneumonia.
Arai Y; Obinata K; Sato Y; Hisata K; Tadokoro R; Tawa T; Kinoshita K
Eur J Pediatr; 2001 Jul; 160(7):425-9. PubMed ID: 11475580
[TBL] [Abstract][Full Text] [Related]
13. [Surfactant proteins A and D as biomarkers of disease activity in diffuse interstitial pneumonia].
Abe S; Takahashi H
Nihon Kokyuki Gakkai Zasshi; 2000 Mar; 38(3):157-65. PubMed ID: 10846395
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis.
Yanaba K; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2004 Jun; 31(6):1112-20. PubMed ID: 15170923
[TBL] [Abstract][Full Text] [Related]
15. Gefitinib-induced interstitial lung disease showing improvement after cessation: disassociation of serum markers.
Kitajima H; Takahashi H; Harada K; Kanai A; Inomata S; Taniguchi H; Saikai T; Abe S
Respirology; 2006 Mar; 11(2):217-20. PubMed ID: 16548909
[TBL] [Abstract][Full Text] [Related]
16. Forensic application of three interstitial pneumonia markers: search for new pneumonia markers in dead bodies.
Okaba K; Inokuchi G; Horioka K; Iwase H; Inoue H; Motomura A; Ishii N; Moue C; Shiomi T; Yajima D
Int J Legal Med; 2024 Jul; 138(4):1583-1592. PubMed ID: 38379061
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of levels of lung surfactant protein A in serum, in various lung diseases].
Abe S; Honda Y; Ando M; Saita N; Kida K; Jinno S; Kondo A; Kuroki Y; Akino T
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1219-25. PubMed ID: 8583713
[TBL] [Abstract][Full Text] [Related]
18. KL-6, surfactant protein A and D in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.
Kunitake R; Kuwano K; Yoshida K; Maeyama T; Kawasaki M; Hagimoto N; Hara N
Respiration; 2001; 68(5):488-95. PubMed ID: 11694811
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of sialylated carbohydrate antigens, KL-6, CA19-9 and SLX as serum markers for interstitial pneumonia.
Yokoyama A; Kohno N; Kondo K; Ueda S; Hirasawa Y; Watanabe K; Takada Y; Hiwada K
Respirology; 1998 Sep; 3(3):199-202. PubMed ID: 9767620
[TBL] [Abstract][Full Text] [Related]
20. [Lung injury and serum markers].
Suwabe A
Rinsho Byori; 2002 Nov; 50(11):1061-6. PubMed ID: 12491603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
